TMCnet News
N-of-One Selected by BloodCenter of Wisconsin to Provide Patient-Specific Molecular Interpretation for Next Generation Sequencing of Hematologic MalignanciesLEXINGTON, Mass. --(Business Wire)-- N-of-One, Inc., the leader in clinical interpretation for precision medicine in oncology, today announced an agreement with BloodCenter of Wisconsin. Under this agreement, N-of-One will provide clinical interpretation for BloodCenter of Wisconsin's HemeOnc panel for the diagnosis, prognosis, and risk stratification of hematologic malignancies Next Generation Sequencing technology. Financial terms of the agreement were not disclosed. BloodCenter's Diagnostic Laboratories help physicians provide clinical care to patients worldwide, fostering better understanding and treatment options for patients with difficult-to-diagnose blood related diseases. In addition, the laboratories collaborate with other institutions and industry partners to bring new diagnostic testing and treatment options to patient care. Their newest area of expertise is in the field of Molecular Oncology: BloodCenter offers molecular testing for diagnostic and prognostic markers within acute myeloid leukemia (AML), myeloproliferative neoplasms (MPN), and chronic myelogenous leukemia (CML). These testing menus are built around testing algorithms as recommended by peer reviewed treatment guidelines such as the National Comprehensive Cancer Network (NCCN) and World Health Organization (WHO). N-of-One is leveraging its leading interpretation methodology and processes developed to provide BloodCnter of Wisconsin with gold standard interpretation. BloodCenter and N-of-One have worked closely to select and efficiently deliver the N-of-One clinical and scientific analysis that will support the BloodCenter's clinical reports. N-of-One delivers highly scalable, cost-effective clinical interpretation that is patient specific and can be configured to the needs of each patient sample. "BloodCenter of Wisconsin selected N-of-One because of their high quality clinical interpretation which addresses the specific features of each patient's molecular profile," said Dr. D. P. Dash, Director of the Molecular Oncology Laboratory at BloodCenter of Wisconsin. "N-of-One is very pleased to support BloodCenter of Wisconsin," said Chris Cournoyer, CEO of N-of-One. "We are committed to helping BloodCenter of Wisconsin serve the growing demand for molecular profiling to identify additional treatment strategies for patients fighting hematologic malignancies by delivering cost-effective, gold standard interpretation that is both patient specific and tailored to meet their clinical NGS reporting requirements." About BloodCenter of Wisconsin BloodCenter of Wisconsin is a not-for-profit organization that specializes in blood services, organ, tissue and marrow donation, diagnostic testing, medical services and leading-edge research. BloodCenter of Wisconsin is the only provider of blood to 56 hospitals in 29 Wisconsin counties as well as providing support to hospitals and patients across the country. BloodCenter of Wisconsin advances patient care by delivering life-saving solutions grounded in unparalleled medical and scientific expertise. For more information, visit www.bcw.edu. About N-of-One N-of-One, a leader in enabling precision medicine for oncology, leverages its world-class team of experts coupled with a highly proprietary platform that allows us to provide clinical solutions and services, such as molecular interpretation, to clinicians at the point of care. N-of-One's team of experts has interpreted thousands of samples for oncologists and patients worldwide, through partnerships with leading diagnostic companies, hospital systems, directly to oncologists and through employee access benefit programs. N-of-One does not provide medical advice or promote any product or service. For more information, please visit www.n-of-one.com or call 617-202-9808.
|
